Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions

Rett syndrome (RTT) and Fragile X syndrome (FXS) are two monogenetic neurodevelopmental disorders with complex clinical presentations. RTT is caused by mutations in the Methyl-CpG binding protein 2 gene (MECP2) altering the function of its protein product MeCP2. MeCP2 modulates gene expression by bi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Snow Bach, Stephen Shovlin, Michael Moriarty, Barbara Bardoni, Daniela Tropea
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f731154bbfce4893bd006805e26bd252
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f731154bbfce4893bd006805e26bd252
record_format dspace
spelling oai:doaj.org-article:f731154bbfce4893bd006805e26bd2522021-11-19T06:48:22ZRett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions1662-510210.3389/fncel.2021.764761https://doaj.org/article/f731154bbfce4893bd006805e26bd2522021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fncel.2021.764761/fullhttps://doaj.org/toc/1662-5102Rett syndrome (RTT) and Fragile X syndrome (FXS) are two monogenetic neurodevelopmental disorders with complex clinical presentations. RTT is caused by mutations in the Methyl-CpG binding protein 2 gene (MECP2) altering the function of its protein product MeCP2. MeCP2 modulates gene expression by binding methylated CpG dinucleotides, and by interacting with transcription factors. FXS is caused by the silencing of the FMR1 gene encoding the Fragile X Mental Retardation Protein (FMRP), a RNA binding protein involved in multiple steps of RNA metabolism, and modulating the translation of thousands of proteins including a large set of synaptic proteins. Despite differences in genetic etiology, there are overlapping features in RTT and FXS, possibly due to interactions between MeCP2 and FMRP, and to the regulation of pathways resulting in dysregulation of common molecular signaling. Furthermore, basic physiological mechanisms are regulated by these proteins and might concur to the pathophysiology of both syndromes. Considering that RTT and FXS are disorders affecting brain development, and that most of the common targets of MeCP2 and FMRP are involved in brain activity, we discuss the mechanisms of synaptic function and plasticity altered in RTT and FXS, and we consider the similarities and the differences between these two disorders.Snow BachSnow BachStephen ShovlinMichael MoriartyBarbara BardoniDaniela TropeaDaniela TropeaDaniela TropeaFrontiers Media S.A.articleRett syndromeFragile X syndromesynaptic plasticityFMRPMeCP2neurodevelopmental disordersNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Cellular Neuroscience, Vol 15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Rett syndrome
Fragile X syndrome
synaptic plasticity
FMRP
MeCP2
neurodevelopmental disorders
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Rett syndrome
Fragile X syndrome
synaptic plasticity
FMRP
MeCP2
neurodevelopmental disorders
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Snow Bach
Snow Bach
Stephen Shovlin
Michael Moriarty
Barbara Bardoni
Daniela Tropea
Daniela Tropea
Daniela Tropea
Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
description Rett syndrome (RTT) and Fragile X syndrome (FXS) are two monogenetic neurodevelopmental disorders with complex clinical presentations. RTT is caused by mutations in the Methyl-CpG binding protein 2 gene (MECP2) altering the function of its protein product MeCP2. MeCP2 modulates gene expression by binding methylated CpG dinucleotides, and by interacting with transcription factors. FXS is caused by the silencing of the FMR1 gene encoding the Fragile X Mental Retardation Protein (FMRP), a RNA binding protein involved in multiple steps of RNA metabolism, and modulating the translation of thousands of proteins including a large set of synaptic proteins. Despite differences in genetic etiology, there are overlapping features in RTT and FXS, possibly due to interactions between MeCP2 and FMRP, and to the regulation of pathways resulting in dysregulation of common molecular signaling. Furthermore, basic physiological mechanisms are regulated by these proteins and might concur to the pathophysiology of both syndromes. Considering that RTT and FXS are disorders affecting brain development, and that most of the common targets of MeCP2 and FMRP are involved in brain activity, we discuss the mechanisms of synaptic function and plasticity altered in RTT and FXS, and we consider the similarities and the differences between these two disorders.
format article
author Snow Bach
Snow Bach
Stephen Shovlin
Michael Moriarty
Barbara Bardoni
Daniela Tropea
Daniela Tropea
Daniela Tropea
author_facet Snow Bach
Snow Bach
Stephen Shovlin
Michael Moriarty
Barbara Bardoni
Daniela Tropea
Daniela Tropea
Daniela Tropea
author_sort Snow Bach
title Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
title_short Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
title_full Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
title_fullStr Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
title_full_unstemmed Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
title_sort rett syndrome and fragile x syndrome: different etiology with common molecular dysfunctions
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f731154bbfce4893bd006805e26bd252
work_keys_str_mv AT snowbach rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT snowbach rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT stephenshovlin rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT michaelmoriarty rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT barbarabardoni rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT danielatropea rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT danielatropea rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
AT danielatropea rettsyndromeandfragilexsyndromedifferentetiologywithcommonmoleculardysfunctions
_version_ 1718420352034406400